News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
18,586 Results
Type
Article (781)
Company Profile (3)
Press Release (17802)
Section
Business (5032)
Career Advice (2)
Deals (1049)
Drug Delivery (1)
Drug Development (2080)
Employer Resources (1)
FDA (345)
Job Trends (306)
News (8513)
Policy (719)
Tag
Academia (23)
Allergies (1)
Alliances (1546)
ALS (3)
Alzheimer's disease (7)
Approvals (351)
Artificial intelligence (13)
Autoimmune disease (1)
Automation (2)
Bankruptcy (7)
Best Places to Work (252)
Biosimilars (1)
Biotechnology (5)
Bladder cancer (6)
Brain cancer (1)
Breast cancer (3)
Cancer (77)
Cardiovascular disease (12)
Career advice (2)
CAR-T (1)
Cell therapy (6)
Clinical research (1703)
Collaboration (24)
Compensation (9)
Complete response letters (1)
COVID-19 (143)
C-suite (12)
Data (87)
Depression (1)
Diabetes (12)
Diagnostics (307)
Drug discovery (3)
Drug pricing (1)
Earnings (2118)
Editorial (1)
Employer resources (1)
Events (2878)
Executive appointments (24)
FDA (378)
Funding (17)
Gene editing (1)
Generative AI (2)
Gene therapy (5)
GLP-1 (58)
Government (65)
Guidances (1)
Healthcare (589)
Huntington's disease (1)
Immunology and inflammation (1)
Indications (2)
Infectious disease (148)
Inflammatory bowel disease (5)
Inflation Reduction Act (1)
Influenza (6)
Intellectual property (2)
IPO (446)
IRA (2)
Job creations (70)
Job search strategy (2)
Layoffs (5)
Legal (177)
Liver cancer (1)
Lung cancer (28)
Lymphoma (7)
Manufacturing (2)
MASH (2)
Medical device (548)
Medtech (548)
Mergers & acquisitions (623)
Metabolic disorders (19)
Multiple sclerosis (1)
Neurodegenerative disease (2)
Neuroscience (17)
NextGen: Class of 2025 (89)
Non-profit (20)
Obesity (8)
Opinion (1)
Ovarian cancer (1)
Pain (2)
Pancreatic cancer (6)
Parkinson's disease (3)
Patents (2)
Patient recruitment (3)
Peanut (1)
People (1281)
Phase I (551)
Phase II (794)
Phase III (586)
Pipeline (56)
Policy (3)
Postmarket research (65)
Preclinical (233)
Press Release (1)
Radiopharmaceuticals (5)
Real estate (112)
Recruiting (1)
Regulatory (543)
Reports (3)
Research institute (26)
RSV (2)
Series A (4)
Series B (6)
Startups (91)
Supply chain (1)
Vaccines (28)
Venture capitalists (2)
Weight loss (4)
Date
Today (8)
Last 7 days (36)
Last 30 days (107)
Last 365 days (988)
2025 (352)
2024 (1019)
2023 (1051)
2022 (2138)
2021 (1791)
2020 (1278)
2019 (925)
2018 (813)
2017 (1036)
2016 (1058)
2015 (1207)
2014 (819)
2013 (558)
2012 (711)
2011 (641)
2010 (596)
Location
Africa (9)
Alabama (2)
Arizona (4)
Asia (531)
Australia (159)
California (112)
Canada (34)
Colorado (2)
Connecticut (27)
Europe (6881)
Florida (33)
Georgia (2)
Illinois (3)
Indiana (3)
Japan (2)
Maryland (38)
Massachusetts (149)
Michigan (2)
Minnesota (3)
Missouri (1)
Nebraska (1)
Nevada (22)
New Hampshire (1)
New Jersey (60)
New York (11)
North Carolina (7)
Northern California (52)
Pennsylvania (17)
Rhode Island (1)
South America (12)
South Carolina (1)
Southern California (36)
Texas (22)
United States (504)
Utah (3)
Virginia (2)
Washington State (1)
18,586 Results for "thrombogenics nv".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million
April 24, 2025
·
5 min read
Press Releases
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast
April 8, 2025
·
1 min read
Press Releases
Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo
May 8, 2025
·
10 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update
April 29, 2025
·
27 min read
Press Releases
NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th
April 7, 2025
·
1 min read
Press Releases
Vivoryon Therapeutics N.V. to Report Full Year 2024 Financial Results and Operational Progress on April 29, 2025
April 17, 2025
·
3 min read
Press Releases
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay
April 2, 2025
·
4 min read
Press Releases
Press Release Biocartis NV: Biocartis Announces Multiple Abstracts Demonstrating the Impact of Idylla™ in Oncology Diagnostics to be Presented at USCAP 2025 Annual Meeting
March 18, 2025
·
8 min read
Press Releases
Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers
February 19, 2025
·
8 min read
Press Releases
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
January 27, 2025
·
3 min read
1 of 1,859
Next
